SCHEMBL18075992

SCHEMBL18075992

CCc1ccc(CCO)c(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
NLRP1 Q9C000 1/20 0.41
TRPA1 O75762 1/20 0.41
PDE4B Q07343 2/20 0.38
KDM5A P29375 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
KDM5B Q9UGL1 1/20 0.36
CSNK2A2 P19784 1/20 0.36
CSNK2B P67870 1/20 0.36
CSNK2A1 P68400 1/20 0.36
CSNK2A3 Q8NEV1 1/20 0.36
BACE1 P56817 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2A6 P11509 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ALOX5 P09917 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8772771 0.84 TRPA1 (0.43) LMNAMAPK1NLRP1TRPA1KDM5A
SCHEMBL13761460 0.82 TRPA1 (0.45) LMNAMAPK1TRPA1BACE1CYP1A2
SCHEMBL2602714 0.81 LMNA (0.46) LMNAMAPK1NLRP1TRPA1KDM5A
SCHEMBL18097661 0.81 LMNA (0.38) LMNAMAPK1NLRP1TRPA1KDM5A
SCHEMBL12226954 0.78 TRPA1 (0.42) TRPA1BACE1CYP1A2CYP2A6KDM4E
SCHEMBL11200067 0.78 LMNA (0.36) LMNAMAPK1NLRP1TRPA1KDM5A
SCHEMBL16958596 0.77 ALOX5 (0.40) LMNAMAPK1NLRP1ALOX5SIGMAR1
SCHEMBL12763604 0.76 MAPK1 (0.40) LMNAMAPK1NLRP1TRPA1KDM5A
SCHEMBL15778552 0.76 LMNA (0.43) LMNAMAPK1NLRP1KDM4CCSNK2A2
SCHEMBL26325920 0.76 CSNK2A1 (0.49) LMNAMAPK1NLRP1TRPA1CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016145614-A1 TRIAZOLYL PYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-09-22 WO disclosed